Clinical Trial Update: Modulation of Plasmacytoid Dendritic Cell Function in Multiple Sclerosis

View source ↗

Summary

Completed clinical trial evaluating modulation of plasmacytoid dendritic cell function in multiple sclerosis. Sponsor: Rutgers, The State University of New Jers…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Multiple Sclerosis | Status: COMPLETED